140 related articles for article (PubMed ID: 7688988)
1. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia.
Crosier PS; Ricciardi ST; Hall LR; Vitas MR; Clark SC; Crosier KE
Blood; 1993 Aug; 82(4):1151-8. PubMed ID: 7688988
[TBL] [Abstract][Full Text] [Related]
2. Expression of the Kit and KitA receptor isoforms in human acute myelogenous leukemia.
Piao X; Curtis JE; Minkin S; Minden MD; Bernstein A
Blood; 1994 Jan; 83(2):476-81. PubMed ID: 7506952
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.
Reith AD; Ellis C; Lyman SD; Anderson DM; Williams DE; Bernstein A; Pawson T
EMBO J; 1991 Sep; 10(9):2451-9. PubMed ID: 1714377
[TBL] [Abstract][Full Text] [Related]
4. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
5. Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells.
Kanakura Y; Ikeda H; Kitayama H; Sugahara H; Furitsu T
Leuk Lymphoma; 1993 May; 10(1-2):35-41. PubMed ID: 7690631
[TBL] [Abstract][Full Text] [Related]
6. Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia.
Beghini A; Magnani I; Ripamonti CB; Larizza L
Hematol J; 2002; 3(3):157-63. PubMed ID: 12111653
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha (TNF alpha) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNF alpha receptors.
Khoury E; Andre C; Pontvert-Delucq S; Drenou B; Baillou C; Guigon M; Najman A; Lemoine FM
Blood; 1994 Oct; 84(8):2506-14. PubMed ID: 7522632
[TBL] [Abstract][Full Text] [Related]
8. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
[TBL] [Abstract][Full Text] [Related]
9. c-kit expression in human megakaryoblastic leukemia cell lines.
Hu ZB; Ma W; Uphoff CC; Quentmeier H; Drexler HG
Blood; 1994 Apr; 83(8):2133-44. PubMed ID: 7512841
[TBL] [Abstract][Full Text] [Related]
10. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts.
Smolich BD; Yuen HA; West KA; Giles FJ; Albitar M; Cherrington JM
Blood; 2001 Mar; 97(5):1413-21. PubMed ID: 11222388
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein.
Brach MA; Bühring HJ; Gruss HJ; Ashman LK; Ludwig WD; Mertelsmann RH; Herrmann F
Blood; 1992 Sep; 80(5):1224-30. PubMed ID: 1381241
[TBL] [Abstract][Full Text] [Related]
13. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
[TBL] [Abstract][Full Text] [Related]
14. Expression of the adaptor protein Lnk in leukemia cells.
Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
[TBL] [Abstract][Full Text] [Related]
15. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody YB5.B8 identifies the human c-kit protein product.
Lerner NB; Nocka KH; Cole SR; Qiu FH; Strife A; Ashman LK; Besmer P
Blood; 1991 May; 77(9):1876-83. PubMed ID: 1708291
[TBL] [Abstract][Full Text] [Related]
17. The c-kit molecule and the surface immunophenotype of human acute leukemia.
Kubota A; Okamura S; Shimoda K; Harada M; Niho Y
Leuk Lymphoma; 1994 Aug; 14(5-6):421-8. PubMed ID: 7529077
[TBL] [Abstract][Full Text] [Related]
18. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.
Ikeda H; Kanakura Y; Tamaki T; Kuriu A; Kitayama H; Ishikawa J; Kanayama Y; Yonezawa T; Tarui S; Griffin JD
Blood; 1991 Dec; 78(11):2962-8. PubMed ID: 1720040
[TBL] [Abstract][Full Text] [Related]
19. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
Spiekermann K; Faber F; Voswinckel R; Hiddemann W
Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
[TBL] [Abstract][Full Text] [Related]
20. c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells.
Brizzi MF; Rosso A; Dentelli P; Ferrero D; Lanfrancone L; Pegoraro L
Exp Hematol; 1998 Dec; 26(13):1229-39. PubMed ID: 9845379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
